Black Rock Inc. Sera Prognostics, Inc. Transaction History

Black Rock Inc.

$4.35 Trillion
Q2 2024

A detailed history of Black Rock Inc. transactions in Sera Prognostics, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 1,409,871 shares of SERA stock, worth $10.4 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,409,871

Previous 118,964 1085.12%

Holding current value

$10.4 Million

Previous $1.08 Million 671.35%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$5.6 - $11.69 $7.23 Million - $15.1 Million	1,290,907 Added 1085.12%	1,409,871 $8.35 Million
Q1 2024 May 10, 2024	BUY	$5.05 - $10.0 $156,580 - $310,060	31,006 Added 35.25%	118,964 $1.08 Million
Q4 2023 Feb 13, 2024	BUY	$1.65 - $6.85 $50,042 - $207,753	30,329 Added 52.63%	87,958 $525,000
Q3 2023 Nov 13, 2023	SELL	$1.55 - $3.34 $3,547 - $7,645	-2,289 Reduced 3.82%	57,629 $107,000
Q2 2023 Aug 11, 2023	BUY	$3.0 - $3.98 $36,144 - $47,951	12,048 Added 25.17%	59,918 $197,000
Q1 2023 May 12, 2023	BUY	$1.19 - $4.25 $4,729 - $16,889	3,974 Added 9.05%	47,870 $183,000
Q4 2022 Feb 13, 2023	SELL	$1.16 - $1.8 $13,598 - $21,101	-11,723 Reduced 21.08%	43,896 $55,000
Q3 2022 Nov 14, 2022	BUY	$1.55 - $2.71 $1,771 - $3,097	1,143 Added 2.1%	55,619 $89,000
Q2 2022 Aug 12, 2022	SELL	$1.2 - $3.62 $157,996 - $476,623	-131,664 Reduced 70.73%	54,476 $90,000
Q1 2022 May 12, 2022	BUY	$2.96 - $8.8 $25,805 - $76,718	8,718 Added 4.91%	186,140 $707,000
Q4 2021 Feb 10, 2022	BUY	$6.87 - $11.41 $188,485 - $313,044	27,436 Added 18.29%	177,422 $1.22 Million
Q3 2021 Nov 09, 2021	BUY	$7.9 - $13.04 $1.18 Million - $1.96 Million	149,986 New	149,986 $1.67 Million

Others Institutions Holding SERA

# of Institutions

Shares Held

19M

Call Options Held

35.4K

Put Options Held

View Full List

About SERA PROGNOSTICS, INC.

Ticker SERA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 29,596,900
Market Cap $218M
Description
Sera Prognostics, Inc., a women's health diagnostic company, discovers, develops, and commercializes biomarker tests for improving pregnancy outcomes. The company develops PreTRM test, a blood-based biomarker test to predict the risk of spontaneous preterm birth in asymptomatic singleton pregnancies. It is also developing a portfolio of product ...

More about SERA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.

Account